Live Breaking News & Updates on Brachytherapy|Page 2
Stay updated with breaking news from Brachytherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Henriette Lamprecht – One of every four men will have prostate cancer in their life time. This according to urologist, dr. Emmanuel Johnson, who now offers men in Namibian. ....
Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Wednesday the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with external beam radiotherapy (EBRT) plus concurrent chemotherapy, followed by brachytherapy (concurrent chemoradiotherapy) as treatment with definitive intent for newly diagnosed patients with high-risk locally advanced cervical cancer. ....
Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients. ....